Belite Bio BLTE
NASDAQ BLTE
$155.94 -0.58 (-0.37%)
At close: Nov 11, 2026 · 4:00 PM EST

Belite Bio (BLTE) Long-Term Investments (2025)

Updated

Belite Bio's Long-Term Investments was $280.17 million in Q4 2025, compared with $521,000 a year earlier.

Analysis

Belite Bio (BLTE) Long-Term Investments (2025) Analysis & Trends

From Q4 2022 onward, Belite Bio has reported Long-Term Investments for 5 quarters.

  • Long-Term Investments shows a three-year compound annual growth rate of 603.1% (FY2022 to FY2025).
  • In earlier years, Long-Term Investments was $521,000 in FY2024 (-35.8%), $811,000 in FY2023 (+0.6%) and $806,000 in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 4.01 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 387.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 1.60 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - 63.00 Mn
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 268.00 Mn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 1.45 Bn
10 Belite Bio 6.16 Bn 6.16 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 280.17 Mn
API Access

Belite Bio Long-Term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-investments&ticker=BLTE&period=max&api_key=YOUR_API_KEY